loan and receivables of securities borrowing; (g) receivables of pledging account; (h) any other asset as stipulated by the Notification of the SEC Office. (4) “general liabilities” means total
The financial status of the Company as at June 30, 2018 is as follow Unit : million baht Statement of financial Jun 30, 2018 Dec 31, 2017 Increase (Decrease) Percentage Asset 1,205.94 1,103.82 102.12
with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000
2019 is as follows: Unit : million baht Statement of financial 30 Sep 2019 31 Dec 2561 Increase (Decrease) Percentage Asset 1,484.45 1,419.80 64.65 4.55 Liabilities 605.65 462.61 143.04 30.92
the Reviewed Financial Statement of the Company as at 30 September 2018. While the transaction is not considered an asset acquisition which requires approval from a shareholders’ meeting, the entry into
approximately 4.17 percent pursuant to the value of consideration rule calculated from the consolidated financial statement of the Company as of 30 September 2017. During the past six months, there was no asset
from the consolidated audited financial statement of the Company ended September 30, 2018. After the computation of the Transaction size together with the Company’s other acquisition transactions within
Financial Reporting Standard No. 16 : Lease (TFRS 16), effective 1 January 2020, has impacted the Company and its subsidiaries’ financial statement in recognizing a right-of-use asset and a lease liability in
business unit has less revenue than previous year. Management’s discussion and analysis for the Quarter 2’ 2020 5 / 7 4. Financial position Statement of Financial Position – Consolidated (Million Baht) As at